Financial Instruments and Derivative Instruments (Tables)

3 Months Ended

Mar. 29, 2020

Financial Instruments and Derivative Instruments

Schedule of carrying amount and estimated fair market value of the company's long-term debt, including current portion

	March 29,		December 31,
	2020		2019
	(in millions)
Carrying amount	$	380.0	$	310.0
Estimated fair value	$	380.7	$	310.5

Schedule of fair value of financial assets and liabilities

	Fair Value Measurement at March 29, 2020 Using:
			Quoted Prices in Active		Significant Other		Significant
			Markets for Identical		Observable		Unobservable
			Assets		Inputs		Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
	(in millions)
Assets
Plan asset for deferred compensation(1)	$	2.1	$	2.1	$	—	$	—
Designated foreign currency hedges (4)	$	0.6	$	—	$	0.6	$	—
Total assets	$	2.7	$	2.1	$	0.6	$	—
Liabilities
Interest rate swaps (3)	$	1.0	$	—	$	1.0	$	—
Plan liability for deferred compensation(2)	$	2.1	$	2.1	$	—	$	—
Total liabilities	$	3.1	$	2.1	$	1.0	$	—

	Fair Value Measurements at December 31, 2019 Using:
			Quoted Prices in Active		Significant Other		Significant
			Markets for Identical		Observable		Unobservable
			Assets		Inputs		Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
	(in millions)
Assets
Plan asset for deferred compensation(1)	$	2.5	$	2.5	$	—	$	—
Interest rate swaps (1)	$	1.2	$	—	$	1.2	$	—
Total assets	$	3.7	$	2.5	$	1.2	$	—
Liabilities
Plan liability for deferred compensation(2)	$	2.5	$	2.5	$	—	$	—
Designated foreign currency hedge(3)	$	0.2	$	—	$	0.2	$	—
Total liabilities	$	2.7	$	2.5	$	0.2	$	—

(1) Included on the Company’s consolidated balance sheet in other assets (other, net).

(2) Included on the Company’s consolidated balance sheet in accrued compensation and benefits.

(3)Included on the Company’s consolidated balance sheet in accrued expenses and other liabilities.

(4)Included on the Company’s consolidated balance sheet in other current assets (prepaids expenses and other current assets).